Background In the UK, a man’s lifetime risk of being diagnosed with prostate cancer is 1 in 8. We calculated both the lifetime risk of being diagnosed with and dying from prostate cancer by major ethnic group. Methods Public Health England provided prostate cancer incidence and mortality data for England (2008–2010) by major ethnic group. Ethnicity and mortality data were incomplete, requiring various assumptions and adjustments before lifetime risk was calculated using DevCan (percent, range). Results The lifetime risk of being diagnosed with prostate cancer is approximately 1 in 8 (13.3 %, 13.2–15.0 %) for White men, 1 in 4 (29.3 %, 23.5–37.2 %) for Black men, and 1 in 13 (7.9 %, 6.3–10.5 %) for Asian men, whereas that of dying from pr...
OBJECTIVES: Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM...
Aim. Black African and black Caribbean men are two to three times more likely to be diagnosed with p...
International variations in the incidence of testis and prostate cancer are well established. Data f...
Background: Differential uptake of prostate-specific antigen testing in the US and UK has been linke...
OBJECTIVES: To use self-assigned ethnicity to examine patterns of incidence, stage, treatment and su...
Objectives: It is known that African American men have a greater risk of prostate cancer than white ...
IntroductionBlack men are twice as likely to be diagnosed with prostate cancer than White men. Raise...
In their analysis in BMC Medicine, Lloyd et al. provide individual patient lifetime risks of prostat...
Data on the epidemiology of prostate cancer from the 1930s to the present document a dramatic racial...
Background: The aetiology of urological cancers is poorly understood and variations in incidence by ...
BACKGROUND: It is recognised that the risk of prostate cancer is higher in black men than in white m...
Evidence suggests that black men of African and Caribbean backgrounds are disproportionately more af...
OBJECTIVE: To reinvestigate whether South Asian men in the UK are at lower risk of being diagnosed w...
Black men in England have three times the age-adjusted incidence of diagnosed prostate cancer as com...
bout 218,890 new prostate cancer diagnoses were expected in the United States during 2007, with 27,0...
OBJECTIVES: Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM...
Aim. Black African and black Caribbean men are two to three times more likely to be diagnosed with p...
International variations in the incidence of testis and prostate cancer are well established. Data f...
Background: Differential uptake of prostate-specific antigen testing in the US and UK has been linke...
OBJECTIVES: To use self-assigned ethnicity to examine patterns of incidence, stage, treatment and su...
Objectives: It is known that African American men have a greater risk of prostate cancer than white ...
IntroductionBlack men are twice as likely to be diagnosed with prostate cancer than White men. Raise...
In their analysis in BMC Medicine, Lloyd et al. provide individual patient lifetime risks of prostat...
Data on the epidemiology of prostate cancer from the 1930s to the present document a dramatic racial...
Background: The aetiology of urological cancers is poorly understood and variations in incidence by ...
BACKGROUND: It is recognised that the risk of prostate cancer is higher in black men than in white m...
Evidence suggests that black men of African and Caribbean backgrounds are disproportionately more af...
OBJECTIVE: To reinvestigate whether South Asian men in the UK are at lower risk of being diagnosed w...
Black men in England have three times the age-adjusted incidence of diagnosed prostate cancer as com...
bout 218,890 new prostate cancer diagnoses were expected in the United States during 2007, with 27,0...
OBJECTIVES: Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM...
Aim. Black African and black Caribbean men are two to three times more likely to be diagnosed with p...
International variations in the incidence of testis and prostate cancer are well established. Data f...